# Covis Pharma GmBH - Inspection Records Source: https://www.keypedia.com/companies/covis-pharma-gmbh/d1616a5d-a379-4021-b5aa-ef8f369c9a92 > Inspection records and compliance data for Covis Pharma GmBH in Waltham, Massachusetts. Access full analysis and detailed observations. --- ## Details - Name: Covis Pharma GmBH - FEI Number: 3008152278 - City: Waltham - State: Massachusetts - Country Name: United States - Address Line 1: 1100 Winter St - Zip Code: 02451 ## Related Documents - [FDA Inspection 1250807 - Covis Pharma GmBH - 2024-09-19](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/8f50ef65-8fa0-4031-ab2d-117c80dc0f71) — source: FDA, date: September 19, 2024 - [FDA Inspection 1250807 - Covis Pharma GmBH - 2024-09-19](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/9d7b8cb0-e107-4ecb-bc9d-dba336151f37) — classification: No Action Indicated (NAI), source: FDA, date: September 19, 2024 - [EIR - Covis Pharma GmBH - 2019-04-05](https://www.keypedia.com/records/eir/covis-pharma-gmbh/96266907-6479-4062-9364-c049059438c8) — source: FDA, date: April 5, 2019 - [FDA Inspection 1087302 - Covis Pharma GmBH - 2019-04-05](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/db0b80c1-3aa9-41a8-86a7-3ee7ad3c3e1a) — classification: No Action Indicated (NAI), source: FDA, date: April 5, 2019 - [EIR - Covis Pharma GmBH - 2018-10-22](https://www.keypedia.com/records/eir/covis-pharma-gmbh/e1c3ac92-6d3d-4fd5-b444-b1dc9d39cbf4) — source: FDA, date: October 22, 2018 - [FDA Inspection 1071326 - Covis Pharma GmBH - 2018-10-22](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/1514e60a-422a-41a1-8625-2dddda6560dd) — classification: No Action Indicated (NAI), source: FDA, date: October 22, 2018 - [FDA Inspection 981007 - Covis Pharma GmBH - 2016-07-15](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/e03436c5-2531-4b26-94ec-738dabe9dd52) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2016 - [FDA Inspection 892953 - Covis Pharma GmBH - 2014-07-28](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/88fb2b99-8685-4234-b6dc-1010f35b4c7d) — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2014 - [EIR - Covis Pharma GmBH - 2014-05-21](https://www.keypedia.com/records/eir/covis-pharma-gmbh/ca25746d-042f-44fb-9023-feac3e8caca7) — source: FDA, date: May 21, 2014 - [483 - Covis Pharma GmBH - 2014-05-21](https://www.keypedia.com/records/483/covis-pharma-gmbh/d31460cb-08fd-45a3-ab4d-1dbc66de56ec) — source: FDA, date: May 21, 2014 - [FDA Inspection 878312 - Covis Pharma GmBH - 2014-05-21](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/5be48118-00d6-48e0-8f5d-1fc3ce600c79) — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2014 - [FDA Inspection 878312 - Covis Pharma GmBH - 2014-05-21](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/f6c81ab1-8d1b-4f64-b5d9-f3690f5bc2d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 21, 2014 - [EIR - Covis Pharma GmBH - 2013-02-07](https://www.keypedia.com/records/eir/covis-pharma-gmbh/517ef4b2-926e-4c85-b0dc-313096252028) — source: FDA, date: February 7, 2013 - [483 - Covis Pharma GmBH - 2013-02-07](https://www.keypedia.com/records/483/covis-pharma-gmbh/63a7c09e-9210-463a-8653-f60b4b6c0244) — source: FDA, date: February 7, 2013 - [FDA Inspection 819091 - Covis Pharma GmBH - 2013-02-07](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/63acdd29-79f4-4836-874f-c0f3028bca18) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2013 - [FDA Inspection 819091 - Covis Pharma GmBH - 2013-02-07](https://www.keypedia.com/records/fda_inspections/covis-pharma-gmbh/0ff564c0-b397-4e53-85e2-e4e5c77d665e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2013 - [EIR - Covis Pharma GmBH - 2011-08-03](https://www.keypedia.com/records/eir/covis-pharma-gmbh/4da4aee9-e25c-41b5-90be-9cb639c836ff) — source: FDA, date: August 3, 2011 - [483 - Covis Pharma GmBH - 2011-08-03](https://www.keypedia.com/records/483/covis-pharma-gmbh/55b430c0-50f3-46db-9e52-cf8160c30b8d) — source: FDA, date: August 3, 2011 ## Related Companies - [TEI Biosciences, Inc.](https://www.keypedia.com/companies/tei-biosciences-inc/c278d7b4-2ffa-44fa-86c3-e15b039953a3) - [WAVi Co.](https://www.keypedia.com/companies/wavi-co/882afa5a-acc0-467c-be14-85c19552e244) - [PlasmaLab International, Inc.](https://www.keypedia.com/companies/plasmalab-international-inc/3c83faf4-6827-4224-8d97-4fd4fd9a8cc8) - [Forcemech International LLC](https://www.keypedia.com/companies/forcemech-international-llc/4e22e86e-30dc-4412-9a9b-62e2361bbf4f) - [Maria W. Greenwald, MD](https://www.keypedia.com/companies/maria-w-greenwald-md/90154f09-36f0-47b8-af7a-477305fa8505) - [TRIUMPH PHARMACEUTICALS INC](https://www.keypedia.com/companies/triumph-pharmaceuticals-inc/3d5a3dad-b74e-4bd5-910b-22a207d327f4) - [Green Valley Fertility Partners](https://www.keypedia.com/companies/green-valley-fertility-partners/36bc479f-b769-4cde-a291-a171ae6f69fb) - [CellEra LLC](https://www.keypedia.com/companies/cellera-llc/b249865e-010e-4d96-886f-a41f9587c80f) - [Datascope Corp.](https://www.keypedia.com/companies/datascope-corp/93b4afd8-759e-4b70-9257-998288b4752a) - [PIL](https://www.keypedia.com/companies/pil/b7c30279-2c88-43f8-a1eb-021ee85b0c4f) ## Related Officers - [company_representative](https://www.keypedia.com/people/lee-f-allen/08fcb582-4468-4954-9d76-faafde2086a2) - [issuing_officer](https://www.keypedia.com/people/bei-yu/4d50b882-2813-4eb5-8bc5-f7045c7681ed) - [Strategic Expert at NovoNordisk; Retired from FDA](https://www.keypedia.com/people/debra-m-emerson/58bd7fac-28eb-4369-b149-13a24cc00cf7) - [investigator](https://www.keypedia.com/people/stacey-s-degarmo/f0dea08e-f65f-4664-9614-66f1997a95dc) - [CSO at FDA](https://www.keypedia.com/people/justine-m-corson/5f6e4477-f060-47f1-9165-a63fd6a36226)